Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli ...

Investors favor Eli Lilly (LLY), but I argue that Novo (NVO) stock outperforms LLY in almost every aspect while trading at a ...

Eli Lilly dominates obesity and diabetes treatments with soaring tirzepatide sales and promising oral drug data. Find out why ...

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...

Novo Nordisk, the Danish pharmaceutical giant behind the obesity drug Wegovy, said on Wednesday it will cut about 9,000 jobs ...

Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 11.5% of its workforce in an ...

The pharmaceutical giant will axe over 11% of its global workforce as rival Eli Lilly gathers market share in the obesity ...

FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...

COPENHAGEN (Reuters) - Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, will cut 9,000 jobs or 11.5% of its ...